A Colombian cannabis venture has started raising capital in the hungry Canadian public cannabis market.

Thanks to a reverse takeover the Colombian-based Khiron Life Sciences (TSXV:KHRN) has made its public debut on the TSX Venture Exchange on Thursday (May 24) under the ticker symbol “KHRN.”


Alvaro Torres, president and CEO of Khiron told the Investing News Network (INN) the company picked the TSXV to launch the stock of the company because of the security.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

“[The] TSXV w[ill] provide for us a level of comfort for investors and for [the] government of Colombia to know we are doing things the right way,” Torres said.

Things have changed for investors since the time Torres started pitching the opportunity in Colombia. At first the questions were simply on security issues but now, Torres said, the questions are focused on the market and investors are more involved than what he heard a year ago.

“Investors now are also saying that the Canadian market is a bit oversaturated and that there’s opportunities to grow elsewhere,” he said. “If you look at Colombia, [it] is like taking a time machine [back] to five years ago where Canada was.”

Khiron’s public launch indicates the willingness from the TSXV to list enterprises based in markets outside of Canada for an emerging industry such as cannabis.

The company plans to expand its reach in South America with what Torres called a “multidomestic strategy,” meaning working closely with medical cannabis patients and doctors to create brand loyalty, then move into several other markets. He specifically indicated Mexico, Brazil and Argentina as upcoming targets.

The Colombian cannabis opportunity has started to flourish for other Canadian companies, such as Scythian Biosciences (TSXV:SCYB; OTCQB:SCCYF), who announced in April its plans to acquire MMJ Colombia Partners as a way to break into the South American country. The terms of the deal included intricate expectations in order to be completed by the Colombian enterprise.

As of 1:57 p.m EST on Thursday, Khiron’s stock has increased 16 percent to reach C$1.16.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Khiron Life Sciences is a client of the Investing News Network. This article is not paid for content.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws

Keep reading... Show less

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer Chief Financial Officer, and Jason Wild Chairman, will participate in three upcoming conferences:

  • Cowen’s 3rd Annual Boston Cannabis Conference, a virtual event taking place November 30-December 2 , 2020. Jason Ackerman will participate in a panel, U.S. MSOs: The West, on November 30, 2020 at 10:25 a.m. ET . Management will also host one-on-one meetings with investors throughout the conference.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, a virtual event taking place on December 15-16, 2020 . Jason Ackerman is scheduled to participate in a fireside chat on December 16 th at 1:00 p.m. ET . To register for the fireside chat: Click Here
  • 23 rd Annual Needham Virtual Growth Conference, a virtual event taking place January 11-15, 2021 . Jason Ackerman is scheduled to participate in a fireside chat on January 14, 2021 at 2:45 p.m. ET . Management will also host one-on-one meetings with investors throughout the conference. To register for the fireside chat: Click Here

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Keep reading... Show less
  • Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada
  • Agreement with Israeli leader Cantek provides access to Israel’s drugstore channel
  • Finished product is co-branded under Aurora and Cantek brands

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today it has entered into a strategic Supply Agreement (the “Agreement”) with Cantek Holdings (“Cantek”), one of Israel’s leaders in the medical cannabis field.

Keep reading... Show less